Long-term therapeutic effects of synthetic bryostatin-1 in advanced ad without memantine
Ended Project Grant Awarded Last action
- Award ID
- R44AG066366
- Recipient
-
Synaptogenix, Inc. UEI LQ2CHPJK6P85
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,168,271
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Funding
-
- $4,435,878.62 Federal
- $1,732,392.00 Non-federal
- Place of performance
- New York, NY, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$15,823 | $0 | |
| Amendment | $1,732,392 | $0 | |
| Amendment | $1,732,392 | $1,732,392 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $986,918 | $0 |
Quick answers
Who received award R44AG066366?
R44AG066366 was awarded to Synaptogenix, Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2019.
How much is award R44AG066366 worth?
$6,168,271 has been obligated on R44AG066366: $4,435,879 in federal funding and $1,732,392 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award